CVS Health Launches Company To Produce Cheaper Versions Of Expensive Biotech Drugs

CVS Health Launches Company To Produce Cheaper Versions Of Expensive Biotech Drugs

CVS Health is launching a new company, Cordavis, to commercialize and produce biosimilar drugs, the cheaper versions of expensive prescriptions derived from biotechnology.

This content was originally published here.